medline.ch Onkologie Urologische Tumoren

	PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial. Trials Johnson D, Thomas R, Cotton S, Newlands R, Cooper D, McCann S, Vale L, Gillies K, Bex A, Challacombe B, Falloon J, MacLennan G, Narahari K, Nicol D, Sheerin N, Stewart GD, Tran M, Heer R, Soomro N. PMID: 41863008 [PubMed - as supplied by publisher]
	Association between presurgical physical activity and urinary and sexual function in prostate cancer patients treated by radical prostatectomy: A prospective cohort study. Urol Oncol Harper A, Khan M, Imm KR, Grubb RL 3rd, Kim EH, Colditz GA, Wolin KY, Kibel AS, Sutcliffe S, Yang L. PMID: 41862406 [PubMed - as supplied by publisher]
	Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical Perspective. Eur Urol Oncol Duquesne I, Epelbaum I, Prost D, Haberstich M, Suartz CV, Blons H, Taly V, Laurent-Puig P, Horowitz A, Sfakianos JP, Thibault C, Audenet F. PMID: 41862336 [PubMed - as supplied by publisher]
	Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14). Eur Urol Oncol Gillessen S, Gobat K, Cathomas R, Fischer N, Pereira Mestre R, Hermanns T, Rothschild SI, Mach N, Mingrone W, Ciriolo M, Müller B, Erdmann A, Schär C, Mamot C, Bohanes P, Omlin A, Bastian S, Ribi K, Mazzucchelli L, Barizzi J, Horvath LG, Scheinberg T, Mellor R, Schär S, Lin HM, Lim R, Pollak M, Turco F, Rothermundt C. PMID: 41862335 [PubMed - as supplied by publisher]
	MR ProGradeNet A Multi-Resolution Deep Learning Framework for Automated Prostate Cancer Grading from MRI. Semin Ultrasound CT MR Ghag KV, Jagdale J, Vyawahare M. PMID: 41862143 [PubMed - as supplied by publisher]
	Renal cell carcinoma presenting with orbital metastasis as the initial symptom: A case report. Medicine (Baltimore) Wang X, Fan Z, Liu R, Qiao Z, Dong W, Shi S, Liu C. PMID: 41861213 [PubMed - indexed for MEDLINE]
	Patterns of opioid dose escalation in patients with chronic kidney disease initiated on opioids for the treatment of non-cancer pain. PLoS One Zin CS, Lando S, González-Ortiz A, Mahalingasivam V, Mostafaei S, Ahmad WR, Ahmad Shah MM, Wettermark B, Carrero JJ. PMID: 41860838 [PubMed - indexed for MEDLINE]
	Prognostic value of baseline circulating tumor DNA levels in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. Front Immunol Liao Y, Lin Y, Luo B, Shen J. PMID: 41859077 [PubMed - indexed for MEDLINE]
	Active Surveillance for Localized Prostate Cancer: AÂ Retrospective Single-Center Study. Int J Urol Sugino A, Miyazawa Y, Nakazawa S, Tsuji Y, Fujizuka Y, Arai S, Sekine Y, Nomura M, Koike H, Matsui H, Suzuki K. PMID: 41858140 [PubMed - indexed for MEDLINE]
	Clinical Validation of the Prostate Health Index for Detecting Clinically Significant Prostate Cancer in a Population-Based Screening Program. Int J Urol Yaegashi H, Nakashima K, Miwa S, Miyagi T, Takashima M, Koura T, Ohno H, Kaji K, Ito K, Mizokami A. PMID: 41858129 [PubMed - indexed for MEDLINE]
	Can pelvic lymph node dissection be spared in intermediate-risk prostate cancer patients with negative PSMA PET scan? A systematic review and diagnostic meta-analysis. Prostate Cancer Prostatic Dis Wan QC, Min KY, Wei L, Xie LJ, Ji B. PMID: 41857380 [PubMed - as supplied by publisher]
	A prospective head-to-head comparison of (18)F-NYM005 PET/CT and (18)F-FDG PET/CT in diagnosing renal cell carcinoma. Eur J Nucl Med Mol Imaging Nie P, Li B, Luo L, Hou F, Zhang N, Yang H, Huang X, Zhu Z, Ma S, Wu T, Xie J, Zhang M, Yang G, Wang Z. PMID: 41857358 [PubMed - as supplied by publisher]
	Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer. Cancer Prev Res (Phila) Hahm ER, Jacobs BL, Singh KB, Kim SH, Parikh RA, Normolle DP, Dhir R, Oyebamiji T, Sun X, Liu Y, Appleman LJ, Gelhaus SL, Singh SV. PMID: 41856926 [PubMed - as supplied by publisher]
	A Systematic Review and Meta-Analysis of the Significance of Diabetes on Kidney Cancer Outcomes and the Role of Metformin. Clin Genitourin Cancer Kim LH, Tai JY, Li T, Hayler R, Wang H, Lau HM, Pleass H, Nair-Shalliker V, Smith D, Patel MI. PMID: 41856872 [PubMed - as supplied by publisher]
	Editorial Comment on "Mental Health Burden of a Testicular Cancer Diagnosis: Insights from a Large Claims Database". Urology Langston DM. PMID: 41856376 [PubMed - as supplied by publisher]
	Editorial Commentary: "Treatment Selection for Non-Muscle-Invasive Bladder Cancer in an Emerging Treatment Era: A Patient Preference Study. Urology Smelser WW. PMID: 41856374 [PubMed - as supplied by publisher]
	Therapeutic Impact of 18F-PSMA-1007 PET/MRI in staging Intermediate/ High-Risk Prostate Cancer Patients: Imaging Biomarkers and Radiomic Analysis Associated with Tumor Aggressiveness. Rev Esp Med Nucl Imagen Mol (Engl Ed) Garcia JR, Pinilla L, Compte A, Garrido N, Mont-Castro LL, Ruiz S, Garcia Magro J, Santabárbara JM, Tovar D, Mourelo S, Soria M, Riera E. PMID: 41856314 [PubMed - as supplied by publisher]
	Frailty in older adults with cancer: A systematic review of evidence in colorectal, lung, prostate, and hematological malignancies. Rev Esp Geriatr Gerontol Bermejo Boixareu C, Martínez-Velilla N, Neira Álvarez M, Rodriguez-Couso M, Ramírez-Martín R, Mauleón-Ladrero C, González-Senac NM, Hormigo Sánchez AI, Tarazona-Santabalbina FJ, Martínez Peromingo FJ, Abizanda Soler P, Serra Rexach JA, Rodríguez Mañas L. PMID: 41855955 [PubMed - as supplied by publisher]
	Survival modelling of relapse-free survival and competing-risk analysis in patients with high-risk localized prostate cancer treated in GETUG-12. Eur J Cancer Vicier C, Erdogan F, Allouache N, Delva R, Gravis G, Rolland F, Priou F, Ferrero JM, Houede N, Mourey L, Theodore C, Krakowski I, Berdah JF, Baciuchka M, Laguerre B, Fléchon F, Gross-Goupil M, Cojean-Zelek I, Oudard S, Labourey JL, Chinet-Charrot P, Legouffe E, Lagrange JL, Linassier C, Deplanque G, Beuzeboc P, Davin JL, Brihoum M, Culine S, Fizazi K, Le Teuff G. PMID: 41855781 [PubMed - as supplied by publisher]
	ProCausal-WS: Weakly Supervised Causal Representation Learning Driven Interpretable Prostate Cancer Diagnosis. IEEE J Biomed Health Inform Kong W, Liu W, Du H. PMID: 41855066 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 176955

Seite 1 von 8848

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung